Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Eli Lilly And Co (LLY) – Eli Lilly And Co Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Eli Lilly (LLY) trades at $907.10, down 2.15% amid bearish technical signals but maintains strong fundamentals with robust earnings beats and 31.67% net margins. The stock shows oversold conditions with RSI at 28, trading near key support at $906. Recent news highlights potential $2B acquisition of Kelonia Therapeutics and mixed reception for new obesity pill Foundayo, while institutional buying continues. Revenue growth accelerated to $45B in 2024 with projected $65.2B for 2025.
LLY presents a growth story with expanding profit margins and dominant market position in weight-loss drugs, though valuation multiples remain elevated. Key risks include regulatory scrutiny of new drugs and competitive pressure from Novo Nordisk. Analyst consensus remains strongly bullish with $1,230 price target representing 35% upside, supported by 73% buy ratings from coverage firms.
Read full analysis

Key Stats

  • Market Cap
    $821.80B
  • Sector
    Health
  • 3M Drawdown
    -20.67%
  • Enterprise Value
    $857.03B
  • Dividend Yield
    0.68%
  • Trading Activity
    90% Buy | 10% Sell
  • Typical Hold Time
    88 days
$911.65
52W Low: $625.65
08 Aug 2025
52W High: $1,109.94
25 Nov 2025

Eli Lilly And Co (LLY) is currently valued at a market capitalization of $821.80B, with an enterprise value of $857.03B. Over the past 52 weeks, Eli Lilly And Co has traded between a low of $625.65 and a high of $1,109.94, highlighting its annual price range. Over the past three months, Eli Lilly And Co has recorded a drawdown of -20.67%, reflecting recent price volatility. Eli Lilly And Co offers a dividend yield of 0.68%, with the most recent dividend of $1.73 paid on 13 Feb 26. On average, investors hold Eli Lilly And Co for approximately 88 days, indicating typical investor behavior on the platform.

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer


Technical Indicators
|
|
|
Overall Summary
Bearish (17)Neutral (3)Bullish (7)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $821.80B
  • Sector
    Health
  • 3M Drawdown
    -20.67%
  • Enterprise Value
    $857.03B
  • Dividend Yield
    0.68%
  • Trading Activity
    90% Buy | 10% Sell
  • Typical Hold Time
    88 days
$911.65
52W Low: $625.65
08 Aug 2025
52W High: $1,109.94
25 Nov 2025

Eli Lilly And Co (LLY) is currently valued at a market capitalization of $821.80B, with an enterprise value of $857.03B. Over the past 52 weeks, Eli Lilly And Co has traded between a low of $625.65 and a high of $1,109.94, highlighting its annual price range. Over the past three months, Eli Lilly And Co has recorded a drawdown of -20.67%, reflecting recent price volatility. Eli Lilly And Co offers a dividend yield of 0.68%, with the most recent dividend of $1.73 paid on 13 Feb 26. On average, investors hold Eli Lilly And Co for approximately 88 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!